Jim Simons
APRE icon

Jim Simons’s Aprea Therapeutics APRE Stock Holding History

Jim Simons’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1K Buy
+25,100
New +$19.7K ﹤0.01% 3173
2023
Q1 		– Sell
-8,960
Closed -$59K – 3958
2022
Q4 		$59K Sell
8,960
-5,167
-37% -$54.5K ﹤0.01% 3765
2022
Q3 		$184K Sell
14,127
-1,461
-9% -$25.9K ﹤0.01% 3410
2022
Q2 		$234K Buy
15,588
+693
+5% +$16K ﹤0.01% 3577
2022
Q1 		$554K Buy
14,895
+799
+6% +$32.7K ﹤0.01% 3121
2021
Q4 		$809K Buy
+14,096
New +$1.25M ﹤0.01% 2802

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jim Simons's APRE Position: Q1 2026 in Review

Jim Simons opened a new position in Aprea Therapeutics (APRE) in Q1 2026: 25,100 shares worth $19.1K. The stake represents ﹤0.01% of the portfolio and ranks #3173 among its holdings. This is a return to the name: Jim Simons previously reported a position in APRE as recently as Q4 2022.

Jim Simons first reported a position in APRE in Q4 2021 and has held it in 6 quarters since. The position peaked at $809K in Q4 2021. 22 funds tracked by Wall St. Rank hold APRE as of Q1 2026.

  • Jim Simons held 25,100 shares of Aprea Therapeutics worth $19.1K as of Q1 2026.
  • Aprea Therapeutics was a new Jim Simons position in Q1 2026.
  • Aprea Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3173 holding.
  • Jim Simons first reported a position in Aprea Therapeutics in Q4 2021 and has held it in 6 quarters since.
  • Jim Simons's Aprea Therapeutics position peaked at $809K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.